Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay
September 21, 2022
Euromonitor
24
PDF
Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay
Abstract Retail sales of cough, cold and allergy (hay fever) remedies demonstrated accelerated growth in current value terms in 2022, following the cessation of COVID-19 vaccine program at the end of 2021. As masks were abandoned and consumers returned to their normal out-of-home activities, they became more susceptible to the germs associated with colds, influenza and other respiratory ailments. In 2021, measures such as social distancing, mask wearing and regular hand washing, combined with higher flu...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Content Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay
List Of Contents And Tables
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN URUGUAY KEY DATA FINDINGS 2022 DEVELOPMENTS Partial recovery for cough, cold and allergy remedies, as consumers resume their normal activities Sanofi-Aventis Uruguay retains its leading position, amid share erosion from the smallest players Growth stalls for e-commerce, as consumers return to normal shopping patterns PROSPECTS AND OPPORTUNITIES Consumption set to rebound as consumers return to pre-pandemic lifestyles, although seasonality remains a key factor Medicated confectionery to benefit from an emphasis on sugar-free products E-commerce will continue to grow, amid growing digitalisation and consumer demand for greater convenience CATEGORY DATA Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022 Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022 Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022 Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022 Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027 Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027 CONSUMER HEALTH IN URUGUAY EXECUTIVE SUMMARY Consumer health in 2022: The big picture 2022 key trends Competitive landscape Retailing developments What next for consumer health? MARKET INDICATORS Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022 Table 8 Life Expectancy at Birth 2017-2022 MARKET DATA Table 9 Sales of Consumer Health by Category: Value 2017-2022 Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022 Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022 Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022 Table 13 Distribution of Consumer Health by Format: % Value 2017-2022 Table 14 Distribution of Consumer Health by Format and Category: % Value 2022 Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027 Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027 APPENDIX OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches DISCLAIMER DEFINITIONS SOURCES Summary 1 Research Sources
Retail sales of cough, cold and allergy (hay fever) remedies demonstrated accelerated growth in current value terms in 2022, following the cessation of COVID-19 vaccine program at the end of 2021. As masks were abandoned and consumers returned to their normal out-of-home activities, they became more susceptible to the germs associated with colds, influenza and other respiratory ailments. In 2021, measures such as social distancing, mask wearing and regular hand washing, combined with higher flu...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay
List Of Contents And Tables
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN URUGUAY KEY DATA FINDINGS 2022 DEVELOPMENTS Partial recovery for cough, cold and allergy remedies, as consumers resume their normal activities Sanofi-Aventis Uruguay retains its leading position, amid share erosion from the smallest players Growth stalls for e-commerce, as consumers return to normal shopping patterns PROSPECTS AND OPPORTUNITIES Consumption set to rebound as consumers return to pre-pandemic lifestyles, although seasonality remains a key factor Medicated confectionery to benefit from an emphasis on sugar-free products E-commerce will continue to grow, amid growing digitalisation and consumer demand for greater convenience CATEGORY DATA Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022 Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022 Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022 Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022 Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027 Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027 CONSUMER HEALTH IN URUGUAY EXECUTIVE SUMMARY Consumer health in 2022: The big picture 2022 key trends Competitive landscape Retailing developments What next for consumer health? MARKET INDICATORS Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022 Table 8 Life Expectancy at Birth 2017-2022 MARKET DATA Table 9 Sales of Consumer Health by Category: Value 2017-2022 Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022 Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022 Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022 Table 13 Distribution of Consumer Health by Format: % Value 2017-2022 Table 14 Distribution of Consumer Health by Format and Category: % Value 2022 Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027 Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027 APPENDIX OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches DISCLAIMER DEFINITIONS SOURCES Summary 1 Research Sources